CEO-TWO (Beutlich Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the CEO-TWO drug offered from Beutlich Pharmaceuticals, LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Beutlich Pharmaceuticals, LLC
NON-PROPRIETARY NAME: Laxative
SUBSTANCE NAME: POTASSIUM BITARTRATE; SODIUM BICARBONATE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: RECTAL
DOSAGE FORM: SUPPOSITORY
MARKETING CATEGORY NAME: OTC MONOGRAPH NOT FINAL
START MARKETING DATE: 2008-08-15
END MARKETING DATE: 0000-00-00


CEO-TWO HUMAN OTC DRUG Details:

Item DescriptionCEO-TWO from Beutlich Pharmaceuticals, LLC
LABELER NAME: Beutlich Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 927; 618(mg/3.7g; mg/3.7g)
START MARKETING DATE: 2008-08-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0283-0808_fe0fc90b-8151-4cde-b7b9-461840203417
PRODUCT NDC: 0283-0808
APPLICATION NUMBER: part334

Other POTASSIUM BITARTRATE; SODIUM BICARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Beutlich Pharmaceuticals, LLCCEO-TWO